Iodine-131 Rituximab Radioimmunotherapy with BEAM Conditioning and Autologous Stem Cell Transplant Salvage Therapy for Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma-Reference-Cited by-同舟云学术

Iodine-131 Rituximab Radioimmunotherapy with BEAM Conditioning and Autologous Stem Cell Transplant Salvage Therapy for Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma

Published:2012-11 Issue:9 Volume:27 Page:552-560
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Kruger Paul C.¹,Cooney Julian P.²,Turner J. Harvey³

Affiliation:

1. Department of Hematology, Fremantle Hospital, The University of Western Australia, Fremantle, Australia.

2. Department of Hematology, Royal Perth Hospital, Perth, Australia.

3. Department of Nuclear Medicine, Fremantle Hospital, The University of Western Australia, Fremantle, Australia.

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/cbr.2012.1275

Reference70 articles.

1. Epidemiology of non-Hodgkin?s lymphoma (NHL): trends, geographic distribution, and etiology

2. Autologous Bone Marrow Transplantation in Non-Hodgkin's Lymphoma

3. High-Dose Therapy and Autologous Bone Marrow Transplantation after Failure of Conventional Chemotherapy in Adults with Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma

4. Parma international protocol: pilot study of DHAP followed by involved- field radiotherapy and BEAC with autologous bone marrow transplantation

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Theranostics of Hematologic Disorders;Nuclear Medicine and Immunology;2021-11-25

2. Cancer Immunotherapy Confers a Global Benefit;Cancer Immunology;2020

3. Radioimmunotherapy-based conditioning regimen prior to autologous stem cell transplantation in non-Hodgkin lymphoma;International Journal of Hematologic Oncology;2018-03-01

4. Current trials for frontline therapy of mantle cell lymphoma;Journal of Hematology & Oncology;2018-01-27

5. Comparison of CBV, BEAM and BEAC high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation in non-Hodgkin lymphoma: Efficacy and toxicity;Asia-Pacific Journal of Clinical Oncology;2017-01-19